PSEUDOVITELLIFORM MACULOPATHY SECONDARY TO BRAF AND MEK INHIBITORS IN A PATIENT WITH METASTASIC MELANOMA

被引：0
|
作者：
Alba-Linero, C. [1 ]
Rocha De Lossada, C. [1 ]
Delgado-Fernandez, A. S. [1 ]
Jodar-Marquez, M. [1 ]
Calvo De Mora, M. Rodriguez [1 ]
Berciano-Guerrero, M. A. [2 ]
机构：
[1] Hosp Reg Malaga, Plaza Hosp Civil, Ophthalmol Dept, Malaga 29009, Spain
[2] Hosp Reg Malaga, Oncol Dept, Malaga, Spain
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2019年 / 33卷 / 05期
关键词：
neuroepithelial detachment; metastasic melanoma; BRAF inhibitors; MEK inhibitors; pseudovitelliform;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1497 / 1500
页数：4
相关论文
共 50 条
  • [21] Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors
    Glass, Lora R. Dagi
    Lawrence, Donald P.
    Jakobiec, Frederick A.
    Freitag, Suzanne K.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (05): : E114 - E116
  • [22] Dosing of BRAF and MEK Inhibitors in Melanoma: No Point in Taking a Break
    Lee, Jenny H.
    Carlino, Matteo S.
    Rizos, Helen
    CANCER CELL, 2020, 38 (06) : 779 - 781
  • [23] Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy
    Kuske, Marvin
    Westphal, Dana
    Wehner, Rebekka
    Schmitz, Marc
    Beissert, Stefan
    Praetorius, Christian
    Meier, Friedegund
    PHARMACOLOGICAL RESEARCH, 2018, 136 : 151 - 159
  • [24] Recent developments and obstacles in the treatment of melanoma with BRAF and MEK inhibitors
    Wahid, Mohd
    Jawed, Arshad
    Mandal, Raju K.
    Dar, Sajad A.
    Akhter, Naseem
    Somvanshi, Pallavi
    Khan, Farah
    Lohani, Mohtashim
    Areeshi, Mohammed Y.
    Haque, Shafiul
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 84 - 88
  • [25] Immunotherapy vs BRAF and MEK inhibitors in the treatment of metastatic melanoma
    Casas Hidalgo, I.
    Nieto Gomez, P.
    Rodriguez Delgado, A.
    Alvarez Sanchez, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 376 - 376
  • [26] Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapy
    Spallone, Giulia
    Garofalo, Virginia
    Picchi, Eliseo
    Pitocco, Rossella
    Bianchi, Federico
    Ventura, Alessandra
    Santoni, Riccardo
    Bianchi, Luca
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (02): : 245 - 247
  • [27] A Predictive Model of Adaptive Resistance to BRAF/MEK Inhibitors in Melanoma
    Ruiz, Emmanuelle M.
    Alhassan, Solomon A.
    Errami, Youssef
    Abd Elmageed, Zakaria Y.
    Fang, Jennifer S.
    Wang, Guangdi
    Brooks, Margaret A.
    Abi-Rached, Joe A.
    Kandil, Emad
    Zerfaoui, Mourad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [28] Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma
    Dimitrios C. Ziogas
    Frosso Konstantinou
    Spyros Bouros
    Maria Theochari
    Helen Gogas
    American Journal of Clinical Dermatology, 2021, 22 : 301 - 314
  • [29] Updates and challenges on treatment with BRAF/MEK-inhibitors in melanoma
    Eroglu, Zeynep
    Ozgun, Alpaslan
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (09): : 545 - 551
  • [30] Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors
    Carbonnel, Franck
    Routier, Emilie
    Lazure, Thierry
    Mussini, Charlotte
    Bellanger, Christophe
    Merklen, Carine
    Bejou, Bakhtiar
    Buisson, Anthony
    Amiot, Aurelien
    Meyer, Antoine
    Dong, Catherine
    Robert, Caroline
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (07) : 792 - 799
12345